PharmiWeb.com - Global Pharma News & Resources

Research and development - Press Releases

Date Title Company
01-Nov-2022 Actinium’s Iomab-B is likely to address key unmet need in AML patient group after positive pivotal trial results, says GlobalData GlobalData
01-Nov-2022 CardioPrecision Announces New Investment CardioPrecision
01-Nov-2022 Chiesi Limited responds to NICE evaluation consultation document (ECD) for Lamzede▼® (velmanase alfa) for patients with alpha mannosidosis Chiesi Limited
01-Nov-2022 ProteoNic Announces Broadening of GigaGen’s Rights to 2G UNic™ Technology ProteoNic
01-Nov-2022 Alfa Chemistry Offers Acylation Reagents for Gas Chromatography and Other Instrumental Analytical Methods Alfa Chemistry
01-Nov-2022 CD BioSciences Launches Cell Death Solutions for Life Science Researchers CD BioSciences
01-Nov-2022 CD Bioparticles Introduces Hydrophilic Coatings for Medical Applications CD Bioparticles
01-Nov-2022 CD Bioparticles Launches NIR-Quantum Dots for Biomedical Imaging CD Bioparticles
01-Nov-2022 Amerigo Scientific Launches PicoRaman Spectrometer for Time-resolved Measurements Amerigo Scientific
01-Nov-2022 Amerigo Scientific Launches New Polyclonal Antibody to Human Blood Coagulation Factor XIII Amerigo Scientific
01-Nov-2022 Creative Diagnostics Introduces Fluorometric Neuraminidase Assay Service for High-throughput Discovery Creative Diagnostics
31-Oct-2022 Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System Beckman Coulter Life Sciences
28-Oct-2022 Alfa Chemistry Unveils a New Website for the Supply of Rare Earth Acetates Alfa Chemistry
27-Oct-2022 CD Formulation: One-Stop Pharmaceutical Formulation Solution Makes Drug Development Faster, Easier and More Cost-Effective CD Formulation
26-Oct-2022 Dante Genomics creates separate drug discovery and development company Genomic Biopharma Inc. Dante Genomics
26-Oct-2022 CATALYZE DALLAS LAUNCHES ALMADEN GENOMICS, ENTERING RACE TO ADVANCE PACE OF GENOMIC RESEARCH Catalyze Dallas Holdings
26-Oct-2022 ALMADEN GENOMICS ANNOUNCES LAUNCH OF G.NOME PLATFORM Almaden Genomics
25-Oct-2022 Similis Bio Partners With Blau Farmaceutica to Co-Develop Four Biosimilar Programs Similis Bio
25-Oct-2022 Tenon Medical’s Catamaran(TM) SI Joint Fusion System Receives Institutional Review Board Approval for Two Strategic Post Market Studies Tenon Medical
25-Oct-2022 Intressa Vascular secures EUR 18 million in financing to support the development of its multilayer Allay™ Aortic Stent for the treatment of aortic dissection Intressa Vascular